Skip to content
GenoLensGenoLens

GRHPR

Chr 9p13.2

glyoxylate and hydroxypyruvate reductase

Aliases:
PH2
MANE:
ENST00000318158.11

Annotations refreshed 10 hours ago.

Predicted protein structure

Clinical relevance (Genomics England PanelApp)

Diagnostic Grade (Green)

  • Likely inborn error of metabolism

    BIALLELIC, autosomal or pseudoautosomal
  • Nephrocalcinosis or nephrolithiasis

    BIALLELIC, autosomal or pseudoautosomal
  • Peroxisomal disorders

    BIALLELIC, autosomal or pseudoautosomal
  • Undiagnosed metabolic disorders

    BIALLELIC, autosomal or pseudoautosomal
  • Childhood onset dystonia, chorea or related movement disorder

  • Ductal plate malformation

    BIALLELIC, autosomal or pseudoautosomal

Disease associations (Open Targets)

  • primary hyperoxaluria type 2

    0.78
  • primary hyperoxaluria

    0.67
  • Hyperoxaluria

    0.37
  • nephrocalcinosis

    0.37
  • acute infantile liver failure-cerebellar ataxia-peripheral sensory motor neuropathy syndrome

    0.34
  • nephrolithiasis

    0.33
  • primary hyperoxaluria type 3

    0.09
  • familial idiopathic steroid-resistant nephrotic syndrome

    0.09
  • phosphohydroxylysinuria

    0.08
  • focal segmental glomerulosclerosis

    0.08

Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.

Protein function (UniProt)

Glyoxylate reductase/hydroxypyruvate reductase

Enzyme with hydroxy-pyruvate reductase, glyoxylate reductase and D-glycerate dehydrogenase enzymatic activities. Reduces hydroxypyruvate to D-glycerate, glyoxylate to glycolate, oxidizes D-glycerate to hydroxypyruvate

Data sources: HGNC (CC BY 4.0), AlphaFold (CC BY 4.0, Jumper et al. Nature 2021), Genomics England PanelApp (CC BY 4.0), ClinGen, Open Targets (CC0), UniProt.

Not for sole clinical decision-making. Always verify against primary sources.